Tag: 2017 BIO Investor Forum
“Diverse Candidates Can Win If They Can Get the Interview.”
Diversity is gaining more attention among biotech investors and companies alike. At entry level, 50% …
#BIF17: Looking Ahead to 2018 Policy Landscape
The past year has seen a number of important changes in the legislative and policy …
A Discussion on Value at #BIF17
In a recent op-ed, BIO President and CEO Jim Greenwood wrote about a promising trend …
#BIF17: Turning the Tide on Antimicrobial Resistance
It’s no secret that antimicrobial resistance (AMR) is one of the most serious public health …
Partnering is Key to Success at 2017 BIO Investor Forum
The 2017 BIO Investor Forum is less than a month away, and BIO’s One-on-One Partnering™ …
Exploring the Richness of Companies and Investors at the BIO Investor Forum
The 16th Annual BIO Investor Forum, taking place October 17th-18th in San Francisco, is the …
Antimicrobial Resistance – 2017 BIO Investor Forum to Address Current Status
Alarm bells have been sounding for some time that deadly infections are developing resistance to …
Emerging Biotechs Show Their Stuff at the BIO Investor Forum in San Francisco Oct. 17-18
The next medical breakthrough is most likely under development right now in an early-stage biotech …
Vote for the Next Buzz of BIO at the BIO Investor Forum
Cast your vote for the next Buzz of BIO at the BIO Investor Forum! Vote …
BIO’s Investor Forum: Where Innovative Technology Companies Access Vital Investor Partners for Str...
If you’re an emerging biotech company looking for your first round of funding, San Francisco …